Genentech lung cancer drug flops in clinical trial while eye drug wins FDA approval

The lung cancer drug focused on blocking a protein signal tumors use to cloak themselves from the immune system.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks